Another Health Wildcatters graduate from the startup incubator’s 2014 class reached another significant milestone this week—Silicone Arts Laboratories closed on a $1.5 million funding round.
Silicone was an early highlight among investors. Its flagship product is a synthetic skin and topic filler that can conceal scars and wrinkles, a technology that has potential for other applications such as bandages. The money primarily came from Tennessee-based biosciences investor Innova. The prolific Dallas investment firm Green Park & Golf Ventures also chipped in.
“The company’s traction and growth to date is very impressive, and we were especially attracted to the expanded market opportunities that will come from the continued innovation and product pipeline,” said Jan Bouten, Partner at Innova, in a statement. “We are excited to be a part of their team.”
